Multidisciplinary care and cutting-edge research share space at The Neuro The Montreal Neurological Institute and Hospital (The Neuro) is recognized worldwide for its research and clinical expertise in Parkinson’s disease (PD). PD is a motor neuron disease that is generally associated with old age, but people can also develop it in their thirties and forties. Characteristic symptoms include tremor, rigidity and gait dysfunction, mood and sleep disorders, and cognitive degeneration. About 100,000 Canadians have PD.
Discovery expands our understanding of how we remember sound The ability to remember sounds, and manipulate them in our minds, is incredibly important to our daily lives — without it we would not be able to understand a sentence, or do simple arithmetic. New research is shedding light on how sound memory works in the brain, and is even demonstrating a means to improve it.
March 26 is Purple Day for Epilepsy, a day to support epilepsy awareness worldwide The Neuro has been a world leader in epilepsy treatment and research for more than 60 years. Indeed, the “Montreal Procedure” developed by The Neuro’s founder, Dr. Wilder Penfield, and his colleagues has become the standard operating procedure for the surgical treatment of epilepsy. The Neuro was also a pioneering institute in exploiting electroencephalography (EEG) and magnetic resonance imaging (MRI) to study and treat epilepsy.
Deep learning transforming neuroscience research In an article published in Nature on Feb. 15, 2017, researchers, including principal investigators from the Montreal Neurological Institute’s McConnell Brain Imaging Centre (BIC), used magnetic resonance imaging (MRI) to predict the development of autism in babies.
Health Science Leaders Join Forces to Accelerate Development of Treatments for Neurological Diseases
Montreal, Quebec and Vancouver, British Columbia – Working together to accelerate research into neurological diseases, three leading players in Canada’s health sciences sector are joining forces in a unique multi-million dollar partnership to create a novel drug development platform that will help advance new therapeutics for some of the most debilitating conditions such as amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, and Parkinson’s disease.
Discovery could be key to treating brain and spinal cord injury A foray into plant biology led one researcher to discover that a natural molecule can repair axons, the thread-like projections that carry electrical signals between cells. Axonal damage is the major culprit underlying disability in conditions such as spinal cord injury and stroke.
Research and clinical care complement each other at The Neuro February 28th was Rare Diseases Day, an opportunity to recognize a class of disease that is often overlooked. In the past five years, the Montreal Neurological Institute and Hospital (The Neuro) has made the study and treatment of rare diseases a major priority, hiring new specialists and support staff and coordinating activity under a new research group.
We are pleased to welcome Dr. Stephan Blinder as the new BIC PET physicist on staff. Stephan completed his PhD in Astrophysics (U de Bordeaux I, France) and later shifted his interest towards biomedical imaging research. He worked for 4 years with the MIRG group led by Dr. Anna Celler (U of British Columbia, Vancouver) on SPECT imaging, focusing on 3D and 4D image reconstruction techniques.
CQDM and Brain Canada join forces again in the funding of two new research projects to address unmet needs in brain research CQDM and Brain Canada are proud to announce the funding of two new multi-disciplinary and multi-institutional research projects under the second edition of their Focus on Brain strategic initiative. The partners will award a total of $3M to two research teams to develop cutting-edge tools, technologies and platforms designed to accelerate the discovery of new drugs for brain and nervous system disorders.
Project will enhance mental health access for multicultural communities On Jan. 18, 2017, Bell Let’s Talk announced a donation of $250,000 to McGill University’s Montreal Neurological Institute and Hospital – known as The Neuro – to fund the development of online mental health resources focused on the needs of multicultural communities.
An all-star lineup of experts in the fields of sports and neurology will share a stage on Jan. 27 to discuss concussions, a serious injury that has only recently been getting the attention it deserves.
Have you ever met someone who just wasn’t into music? They may have a condition called specific musical anhedonia, which affects three-to-five per cent of the population. Researchers at the University of Barcelona and the Montreal Neurological Institute and Hospital of McGill University have discovered that people with this condition showed reduced functional connectivity between cortical regions responsible for processing sound and subcortical regions related to reward.
Drug shown to reduce new attacks/symptom progression in some patients In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.